{"id":"NCT00089479","sponsor":"Hoffmann-La Roche","briefTitle":"A Study of Xeloda (Capecitabine) in Women With High-Risk Breast Cancer","officialTitle":"A Randomized, Open-label Study of the Effect of Adjuvant Therapy With Adriamycin Plus Cytoxan Followed by Taxotere or Taxotere Plus Xeloda on Overall Survival in Female Patients With High-risk Breast Cancer","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2002-08","primaryCompletion":"2010-06","completion":"2012-05","firstPosted":"2004-08-06","resultsPosted":"2011-06-23","lastUpdate":"2012-12-21"},"enrollment":2611,"design":{"allocation":"NON_RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Breast Cancer"],"interventions":[{"type":"DRUG","name":"capecitabine [Xeloda]","otherNames":[]},{"type":"DRUG","name":"Taxotere","otherNames":[]},{"type":"DRUG","name":"Taxotere","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"ACTIVE_COMPARATOR"}],"summary":"This 2 arm study will compare the efficacy and safety of Taxotere + Xeloda, versus Taxotere alone, following a regimen of Adriamycin plus Cytoxan in women with high-risk breast cancer. Following 4 cycles of Adriamycin and Cytoxan, patients will be randomized to receive either 1)Taxotere 75mg/m2 iv on day 1 and Xeloda 825mg/m2 po bid on days 1-14 of each 3 week cycle or 2) Taxotere 100mg/m2 iv alone on day 1 of each 3 week cycle. The anticipated time on study treatment is until disease progression, and the target sample size is 500+ individuals.","primaryOutcome":{"measure":"Disease Free Survival [Number of Events]","timeFrame":"Time from the date of randomization until the date of first event, or date last known to be event free if no event was reported. Patients were followed for an average of 5 years.","effectByArm":[{"arm":"AC Then T","deltaMin":164,"sd":null},{"arm":"AC Then XT","deltaMin":140,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":3},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["34037241"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":264,"n":1305},"commonTop":["FATIGUE","NAUSEA","ALOPECIA","NEUTROPENIA","STOMATITIS ALL"]}}